Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RSLS | TMO | ISRG | IDXX | EW |
| Company | Reshape Lifesciences Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Idexx Laboratories | Edwards Lifesciences Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 12.08 | 567.54 | 554.68 | 692.00 | 85.76 |
| High | 18.60 | 572.99 | 561.46 | 705.66 | 86.19 |
| Low | 11.20 | 561.49 | 554.00 | 688.50 | 84.77 |
| Latest | 15.68 | 562.64 | 556.80 | 694.79 | 84.81 |
| Change | +2.88 | -7.52 | +2.22 | +1.61 | -0.51 |
| % Change | +22.50% | -1.32% | +0.40% | +0.23% | -0.60% |
| Volume | 3,435,325 | 1,201,211 | 706,076 | 257,917 | 2,028,194 |
| 20-Day Average Volume | 3,322,765 | 1,560,021 | 1,642,208 | 604,626 | 3,413,120 |
| Previous Close | 12.80 | 570.16 | 554.58 | 693.18 | 85.32 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.67 | 578.08 | 563.18 | 718.16 | 84.93 |
| 20-Day Raw Stochastic | 73.74% | 7.38% | 42.26% | 20.77% | 51.41% |
| 20-Day Relative Strength | 55.44 | 48.53 | 54.29 | 48.40 | 54.65 |
| Weighted Alpha | -93.41 | +14.99 | +6.83 | +62.71 | +16.92 |
| Today's Opinion | 56% Sell | 56% Buy | 64% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 64% Sell | 72% Buy | 64% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 40% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +45.19% since 08/07/25 | -1.84% since 12/10/25 | +0.12% since 12/10/25 | -1.55% since 12/10/25 | +1.23% since 12/10/25 |
| Low | 1.87 on 08/11/25 | 561.00 on 12/16/25 | 537.69 on 12/12/25 | 687.68 on 12/16/25 | 81.85 on 12/15/25 |
| High | 4.65 on 08/14/25 | 579.08 on 12/11/25 | 561.62 on 12/15/25 | 716.45 on 12/11/25 | 86.19 on 12/17/25 |
| 1-Month | |||||
| %Chg | +64.02% since 07/14/25 | -0.69% since 11/17/25 | +1.81% since 11/17/25 | +3.28% since 11/17/25 | +0.25% since 11/17/25 |
| Low | 1.87 on 08/11/25 | 556.46 on 11/18/25 | 537.69 on 12/12/25 | 665.25 on 11/18/25 | 81.85 on 12/15/25 |
| High | 4.65 on 08/14/25 | 602.32 on 11/25/25 | 582.41 on 11/26/25 | 769.98 on 11/26/25 | 87.89 on 12/05/25 |
| 3-Month | |||||
| %Chg | -35.21% since 05/14/25 | +19.18% since 09/17/25 | +28.35% since 09/17/25 | +7.81% since 09/17/25 | +12.97% since 09/17/25 |
| Low | 1.87 on 08/11/25 | 456.67 on 09/29/25 | 427.84 on 10/14/25 | 600.57 on 10/01/25 | 72.30 on 10/13/25 |
| High | 8.29 on 06/03/25 | 602.32 on 11/25/25 | 582.41 on 11/26/25 | 769.98 on 11/26/25 | 87.89 on 12/05/25 |
| 6-Month | |||||
| %Chg | -93.27% since 02/14/25 | +44.33% since 06/17/25 | +8.69% since 06/17/25 | +32.72% since 06/17/25 | +15.95% since 06/17/25 |
| Low | 1.87 on 08/11/25 | 385.46 on 06/18/25 | 427.84 on 10/14/25 | 506.91 on 07/16/25 | 72.30 on 10/13/25 |
| High | 76.25 on 04/01/25 | 602.32 on 11/25/25 | 582.41 on 11/26/25 | 769.98 on 11/26/25 | 87.89 on 12/05/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,353 | 214,213,664 | 198,804,176 | 55,351,112 | 49,511,196 |
| Shares Outstanding, K | 2,386 | 375,708 | 358,477 | 79,851 | 580,300 |
| Annual Sales | 8,010,000 | 42,879,000,000 | 8,352,100,000 | 3,897,500,000 | 5,439,500,000 |
| Annual Net Income | -7,130,000 | 6,335,000,000 | 2,322,600,000 | 887,870,000 | 4,174,600,000 |
| Last Quarter Sales | 1,110,000 | 11,122,000,000 | 2,505,100,000 | 1,105,240,000 | 1,553,100,000 |
| Last Quarter Net Income | 1,470,000 | 1,616,000,000 | 704,400,000 | 274,610,000 | 291,100,000 |
| 60-Month Beta | 1.16 | 0.90 | 1.68 | 1.67 | 0.97 |
| Per-Share Information | |||||
| Most Recent Earnings | 18.98 on 05/20/25 | 5.79 on 10/22/25 | 2.40 on 10/21/25 | 3.40 on 11/03/25 | 0.67 on 10/30/25 |
| Latest Earnings Date | 11/13/25 | 01/29/26 | 01/22/26 | 02/02/26 | 02/10/26 |
| Most Recent Dividend | N/A | 0.430 on 12/15/25 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 12/15/25 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.71 | 78.47 | 55.56 | 32.44 |